I was one of the people that felt sickI couldnt, like, play with my son, she shared
As GLP-1 RAs become more prevalent in treating diabetes and patients with cardiovascular disease (CVD) or risk factors for CVD, clinicians will ultimately manage the practical aspects of patient selection, dosing, special considerations, and side effects of these medications
The differences between the tirzepatide groups and the semaglutide group were statistically significant, showing that tirzepatide was both noninferior and superior to semaglutide
A flat response to both medications despite adequate dosing and adherence is uncommon but real
M.BayerH.WiesnerD.AkimotoC.et al (2013)
What does clinical evidence show about tirzepatide's effectiveness